In this work, we report the synthesis, structural characterization and evaluation of in vitro antioxidant and cytotoxic properties of novel spirobenzothiazolines (1a-e, 2a-e). 5-nonsubstituted spirobenzothiazolines (1a-e) demonstrated notable inhibitory capacity on lipid peroxidation (LPO), reducing power and scavinging effects on diphenylpicryl hydrazine (DPPH˙) and 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS˙+) radicals, that were similar to that of α-tocopherol. The most potent antioxidant was compound 1a (incorporating an ethyl group on the cyclohexane ring) with an anti-LPO activity 2-fold higher than that of α-tocopherol. Compound 1a exhibited anti-LPO and DPPH˙ scavenging activities at concentrations lower than those cytotoxic for mouse normal fibroblast (NIH/3T3) cells and was also found to be slightly more selective for cancer cells (human prostat adenocarcinoma cell/PC-3) than normal mammalian cells.
Introduction
Reactive oxygen species (ROS) are constantly formed in the body during normal cellular metabolism and eliminated by ROS scavenging mechanisms in order to maintain redox balance. The overproduction of ROS through endogenous and/or exogenous factors leads to cell-damaging oxidative stress [1] . Chronic and cumulative oxidative stress exerts detrimental effects on biomolecules such as DNA, proteins and lipids and contributes to the pathogenesis of cancer, rheumatoid arthritis, neurodegenerative diseases, atherosclerosis, diabetes mellitus and other diseases [2] . Some intracellular defences in mamalian cells (superoxide dismutase, glutathione peroxidase and catalase) can protect the cells against the extreme levels of free radicals. Also, exogenous antioxidants such as minerals (zinc, selenium), vitamins (A, C, E, β-karoten) or proteins (transferrin, albumin) have the ability to scavenge the ROS [3] . Thus, the search for new nontoxic compounds with antioxidant activity constitutes a very active search field.
Oxidative stress-induced DNA damage has been commonly accepted as a major cause of cancer. Actually, ROS have contradictory roles in carcinogenesis. They play a key role in tumor formation and progression by causing DNA mutations and genomic instability [1] . On the other hand, many chemotherapeutics and radiotherapy exert cytotoxicity by generating reactive oxygen species since the excessive levels of ROS lead to apoptosis and cell death in cancer cells [4, 5] . Consuming antioxidants in the diet and supplements to prevent and fight diseases, especially cancer, has become very popular among the general public [6] . Antioxidants are also thought to be beneficial in alleviating the adverse effects of chemotherapy and/or radiotherapy [7] . However, the precise mechanism(s) of action of antioxidants in cancer is not yet fully known and clinical trials have still been reporting inconsistent outcomes [1, [4] [5] [6] [7] [8] [9] .
Due to their wide existance in bioactive natural products [10] , spiroheterocycles have been focused on by researchers in chemistry and biology in the past decades. Indole phytoalexins are natural antimicrobial compounds produced by crucifers in response to biotic or abiotic stress [11] . Lowmolecular spiro-phytoalexins such as spirobrassinin (I), 1-methoxyspirobrassinin and 1-methoxyspirobrassinol (II) (Figure 1 ) have been found to possess significant cytostatic/cytotoxic effects against various cancer cells and chemopreventive activity in models of mammary and skin carcinogenesis [12] [13] [14] [15] . In two early reports, spiroindolinones incorporating a benzothiazole or 5-chlorobenzothiazole moiety (III) (Figure 1 ) have been described as promising antioxidants with potent scavenging activities against DPPH˙ and (ABTS˙+) radicals and reducing powers and significant inhibitory capacity on lipid peroxidation. Compounds have also been found to be cytotoxic against some cancer cell lines in anticancer screening [16, 17] . Likewise, the antioxidant properties of several small spiroheterocyclic molecules have been reported in different papers [18] [19] [20] [21] . In this work, we report a series of spirobenzothiazolines that were obtained by condensation of 2-aminothiophenol/2-amino-4-chlorothiophenol and an appropriate ketone. We also report on their in vitro antioxidant activities including; inhibition of lipid peroxidation in liposomes, induced by Fe 3+ /ascorbate system, scavenging effect on DPPH˙, trolox equivalent antioxidant capacity (TEAC) and ferric ion reducing antioxidant power (FRAP), and cytotoxic potentials in vitro against mouse fibroblast (NIH/3T3, CRL-1658) and human prostate adenocarcinoma (PC-3, CRL-1435) cell lines.
Results and Discussion

Chemistry and structural characterization
The spirocyclic benzothiazolines were synthesized by condensation of 2-aminothiophenol/2-amino-4-chlorothiophenol with appropriate ketone in absolute ethanol. Reactions occurred readily under mild temperatures (Scheme 1). Compound 1d was previously reported by Coudert et al. as a potential analgesic [22] . Structures of compounds were established by microanalysis, IR, 1 H-NMR, 13 C-NMR (APT), 2D-NMR (HSQC, HMBC) and electrospray ionization mass spectrometry (ESI-MS). To assist in structural analysis, we have also studied the conformational properties of two compounds, 2a and 2c, by X-ray crystallography [23, 24] .
The IR spectra of compounds 1 and 2 showed N-H stretching bands of the benzothiazole group at 3310-3389 cm -1 . Broad O-H stretching bands for compounds 1e and 2e were observed at 3343-3536 cm -1 region. Aliphatic and aromatic proton resonances of new compounds were found in the expected regions with appropriate coupling constants and integral values. 13 C-NMR experiments (APT) run on 1a, 1c, 1e and 2b-e and 1 H- The proton spectra of both 1a-e and 2a-e displayed two sets of signals for most of the protons. Heteroatom protons N-H and O-H (for compounds 1e and 2e) were observed as two separate singlets. Methyl protons of compounds 1a, 1b and 2a, 2b resonated as two triplets (J=7.3 Hz) and distorted multiplets, respectively. Many of the aromatic and aliphatic proton resonances were detected as duplicated signals or distorted multiplets. Similarly, two signal sets appeared for almost all carbon atoms in the 13 C-NMR spectra of compounds 1a-e and 2a-e. The multiplicity in the signals was thought to result from a conformational difference in spirocyclic ring system. In order to verify the purity of the products, solid structures of compounds 2a and 2c were investigated by X-ray crystallography [23, 24] . The X-ray studies have revealed a slight conformational difference between compounds 2a and 2c. In compound 2a, the 2,3-dihydro-1,3-thiazole ring adopts an envelope with the S,N-bound C atom at the flap, whereas the nine-membered 2,3-dihydro-1,3-benzothiazole ring system is planar in compound 2c. The cyclohexane ring has the expected chair conformation in both compounds. Interestingly, this conformational change leads to a clear difference in hydrogen bondings and crystal packings of two compounds. The crystal packing of 2a is stabilized by intermolecular N-H---S hydrogen bonds, while molecules of 2c are linked by C-H---π interactions. Based on the foregoing data, it can be concluded that compounds 1a-e and 2a-e exist as a mixture of two stable conformers in solution.
Biological activity
Antioxidant activity
In order to evaluate the antioxidant activities of ten spirobenzothiazoline derivatives, as an index of pharmacological usefulness, we decided upon the use of four model systems, namely, inhibition of Fe 3+ -ascorbate induced phospholipid degradation, DPPH˙ and ABTS˙+ radical scavenging activities, and Fe (III) reduction. In the assessment of antioxidant capacity, both synthetically and biologically relevant free radicals were used. DPPH˙ and ABTS˙+ radicals are not biologically relevant, but are commonly used as indicator compounds in testing hydrogen transfer capacity that is related to antioxidant activity. a-Alfa sembolü Tocopherol was used as reference antioxidant. For comparison, Table 1 presents the results of the antioxidant activities, expressed as EC 50 , TEAC and FRAP values.
All of the tested compounds demonstrated the ability to inhibit LPO. Compound 1a was the most efficient inhibitor with the lowest EC 50 value of 0.066±0.002 mM. Its inhibitory effect on Fe +3 /ascorbic acid-induced lipid peroxidation was nearly 2 times higher than that of reference compound, α-tocopherol. Compounds 1b-e and 2a showed almost similar inhibitory effects on TBARS formation, which were not significantly different than that of α-tocopherol.
Compounds 1a-e showed similar degrees of efficacy in their scavenging activities against DPPH˙ and ABTS˙+ radicals. The EC 50 values for these compounds (0.27-0.29 mM) were comparable to that of a-tocopherol (0.28 mM).
In ABTS˙+ scavenging method, the antioxidant activities of the tested compounds were expressed also as the Trolox Equivalent Antioxidant Capacity (TEAC). The TEAC reflects the ability of hydrogen or electron-donating antioxidants to scavenge the ABTS radical cation compared with that of Trolox. There was no significant difference between the TEAC values of 1a-e which were comparable to that of α-tocopherol at the concentration of 2.5 mM, whereas the TEAC values of 2a-e were significantly lower.
FRAP value reflects the electron donation capacity of the compounds. At a concentration of 2.5 mM, 1a-e showed the highest ferric reducing antioxidant powers, which were almost similar to that of the reference at the same concentration.
When these data were examined, it was observed that -Cl substitution at the 5-position of the benzothiazole system had a negative effect on antioxidant activity, since compounds 2a-e were found to be less active in all antioxidant tests carried out. Amongst the compounds 1a-e, R 1 -ethyl substituted 1a was a significantly better inhibitor of lipid peroxidation.
Cytotoxic activity
Compounds 1a-e and 2a-e were further examined for cytotoxicity using the mouse fibroblast (NIH/3T3) and human prostate adenocarcinoma (PC-3) cell lines. The cytotoxicity results presented in Table 2 were expressed as the concentrations inhibiting 50% cell growth (IC 50 ). For six of the test compounds, IC 50 values could not be calculated due to solubility problems. However, maximum deaths in the 1a, 1b, 1c, 2a, 2c and 2d. Compounds 1d, 1e, 2b and 2e were found to be slightly cytotoxic to both normal and cancer cells. Compound 1a which displayed promising antioxidant effects, showed a differential between active and cytotoxic doses. 1a demonstrated anti-LPO (EC 50 =0.066 mM) and DPPH˙ scavenging (EC 50 =0.27 mM) activities at concentrations lower than those cytotoxic for the NIH/3T3 mammalian cells (IC 50 = ˃0.62 mM). Based on the percentage cell death rates, it can be concluded that 1a is slightly more selective for cancer cells (43.5%) than normal mammalian cells (21.4%).
Conclusion
In the search for effective antioxidant agents, we achieved the synthesis of novel spirobenzothiazoline derivatives. The structures were confirmed by microanalysis, spectrometry and X-ray crystallography. In general, 5-nonsubstituted spirobenzothiazolines (1a-e) demonstrated notable inhibitory capacity on lipid peroxidation, reducing power and scavinging effects on DPPH˙ and ABTS˙+ radicals, that were similar to that of α-tocopherol in all antioxidant tests carried out. Compound 1a incorporating an ethyl group on the cyclohexane ring was found to be the most potent antioxidant agent. The compound exhibited strong inhibitory effect on the Fe 3+ /ascorbic acid-induced lipid peroxidation, which was nearly 2-fold higher than that of the reference compound, α-tocopherol. In vitro cytotoxicity of compounds 1a-e and 2a-e against mouse normal fibroblast (NIH/3T3) and human prostat adenocarcinoma (PC-3) cells were further studied. 50% inhibition of cell growth against normal and cancer cells was not achieved for 1a, 1b, 1c, 2a, 2c and 2d derivatives at highest concentrations tested. Compound 1a exhibited anti-LPO and DPPH˙ scavenging activities at concentrations lower than those cytotoxic for normal fibroblast cells. Compound 1a was also found to be slightly more selective for cancer cells than normal mammalian cells.
Materials and Methods
4.1.Chemistry
Melting points were determined in open capillary tubes with a Buchi B-540 melting point apparatus and are uncorrected. Microanalyses were performed on a Thermo Finnigan Flash EA 1112 elemental analyzer. IR spectra were recorded in KBr discs (υ max in cm 
4.1.1.General procedure for the synthesis of 5-chloro/ nonsubstituted-4'-substituted-3H-spiro[1,3-benzothiazole-2,1'-cyclohexanes] (1a-e, 2a-e)
A mixture of 2-aminothiophenol/2-amino-4-chlorothiophenol (0.01 mol) and an appropriate cyclohexanone (0.01 mol) in absolute ethanol (50 mL) was refluxed on a water bath for 8 h. The solvent was evaporated in a crystallizing dish at room temperature and the residue was recrystallized from ethanol/water.
4'-Ethyl-3H-spiro[1,3-benzothiazole-2,1'-cyclohexane](1a)
Beige crystals (56.7%); mp 87. 5 
4'-Propyl-3H-spiro[1,3-benzothiazole-2,1'-cyclohexane](1b)
Brown needles (67.2%); mp 72-74 °C; IR(KBr): υ max =3337 (N-H) [22] White crystals (69.0%); mp 109-110 °C; IR(KBr): υ max =3320 (N-H) [23] Beige crystals (45.5%); mp 108-110 °C; IR(KBr): υ max =3310 (N-H); 
4'-Phenyl-3H-spiro[1,3-benzothiazole-2,1'-cyclohexane](1d)
5-Chloro-4'-ethyl-3H-spiro[1,3-benzothiazole-2,1'-cyclohexane](2a)
5-Chloro-4'-propyl-3H-spiro[1,3-benzothiazole-2,1'-cyclohexane](2b)
Brown needles (61.4%); mp 80-82 °C; IR(KBr): υ max =3379, 3310 (N-H) [24] White crystals (44.3%); mp 180-182 °C; IR(KBr): υ max =3370 (N-H); [1,3- [1,3- 
4'-tert-Butyl-5-chloro-3H-spiro[1,3-benzothiazole-2,1'-cyclohexane](2c)
5-Chloro-4'-phenyl-3H-spiro
5-chloro-4'-(4-hydroxyphenyl)-3H-spiro
Biological activity assays
Antioxidant activity assays Antioxidative effect on lipid peroxidation (LPO)
LPO assay was assessed by the method described by Duh et al. [25] . The formation of LPO products was assayed by the measurement of thiobarbituric acid reactive substances (TBARS) according to Buege and Aust [26] . The percentage inhibition of LPO was calculated using the following equation:
Inhibition effect (%) = (1 -Absorbance of sample/Absorbance of control) x100.
DPPH radical (DPPH˙) scavenging activity
The DPPH˙ scavenging activity of the extract was measured according to the procedure described by Brand-Williams et al. [27] and calculated by the following equation: DPPH˙ scavenging activity (%) = (1 -Absorbance of sample at 517 nm/Absorbance of control at 517 nm) x 100.
Total radical-trapping antioxidant potential (TRAP) assay
The total radical-trapping antioxidant potential of the extract was measured using the trolox equivalent antioxidant capacity (TEAC) assay as described by Re et al. [28] . The ability to scavenge ABTS radical cation (ABTS˙+) was calculated by the following equation:
ABTS˙+ scavenging activity (%) = (1 -Absorbance of sample at 734 nm/Absorbance of control at 734 nm) x 100.
Ferric reducing antioxidant power (FRAP) assay
The FRAP assay was carried out according to the procedure of Benzie and Strain [29] . The standard curve was constructed using iron sulfate heptahydrate solution (0.125 -2 mM), and the results were expressed as mM Fe 2+ equivalents.
Statistical analysis
All measurements were made in triplicate. The results were statistically analyzed with Student's t-test by using the computer software Statistical Package for Social Sciences for windows (SPSS version 21; SPSS, Inc. Chicago IL, USA). Results were considered significant at p < 0.05.
MTT proliferation assay
Cytotoxic potentials of newly synthesized compounds were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in mouse fibroblast (NIH/3T3, CRL-1658) and human prostate adenocarcinoma (PC-3, CRL-1435) cell lines which were obtained from American Type Culture Collection (ATCC, USA). The MTT assay is based on colorimetric changes related to the number of viable cells via mitochondrial activity. In viable cells the yellow tetrazolium salt MTT is reduced into blue/purple colored formazan crystals. The optical density (OD) of the formazan is then read at 590 nm [30] .
Cells were grown in Dulbecco's modified Eagle's medium/ Ham's F-12 (DMEM-F12) supplemented with with 10% fetal bovine serum and 1% antibiotics (100 U/mL penicillin and 100 mg/mL streptomycin) in a humidified incubator with 5% CO 2 at 37 °C. When 80-85% confluency in a flask was provided, cells were trypsinized and seeded at 10 5 cells into each well of 96-well plates. After 24h incubation for cell attachment, cells were treated with various concentrations of the test compounds. The test chemicals were dissolved in dimethyl sulfoxide (DMSO) and diluted in DMEM-F12 that given final concentration range of 0-145 µg/mL. After 24h treatment, 20µL MTT (5 mg/mL in phosphate buffered saline) was added to each well and incubated for 3h at 37 °C. All medium was discarded and formazan crytals were dissolved in 100µL DMSO for 5 min on an orbital shaker to form a homogeneus blue/purple color. ODs were determined at 590 nm, against 670 nm reference wavelength, using a microplate spectrophotometer system (Epoch, Germany). DMEM-F12, 1% DMSO and 1% sodium dodecyl sulfate (SDS) were used as growth, solvent and positive controls in each plate, respectively. Each compound was tested in duplicates in a plate and each plate was repeated in triplicates. All ODs were corrected by substracting the ODs of blank wells and mean OD values of each test chemical were calculated.
The percentage of inhibitory effects of test compounds were calculated as follows: Inhibition% = 100 -( mean cOD of test compound / mean cOD of 1%DMSO)x100 cOD: corrected OD The authors declared no conflict of interest.
